Sarcoidosis developing after COVID‐19: A case report
Abstract COVID‐19 has been implicated in the development of a range of autoimmune diseases and medical consequences. Sarcoidosis is an inflammatory disease with sustained granulomatous inflammation. The possible main pathogenesis of sarcoidosis is a dysregulation between immune response and certain environmental antigens. We present a case of sarcoidosis as an interesting sequela of COVID‐19. The patient was hospitalized due to SARS‐CoV‐2 without complication. Ten weeks after the illness, his chest computed tomography (CT) showed bilateral hilar, paratracheal and subcarinal lymph node enlargement. Endobronchial ultrasound with transbronchial needle aspiration (EBUS‐TBNA) was performed; pathologic findings were that of well‐formed non‐necrotizing granulomas. Complete eye examination reported panuveitis and papillitis in both eyes. On the basis of these findings, sarcoidosis was diagnosed. Therefore, sarcoidosis developing after COVID‐19 was suggested as a possible link between the viral infection and dysregulation of the inflammation process. However, further studies are needed to confirm this association..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
|---|---|
| Enthalten in: |
Respirology Case Reports - 10(2022), 9, Seite n/a-n/a |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dujrath Somboonviboon [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
COVID‐19 |
|---|
| doi: |
10.1002/rcr2.1016 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ024139149 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ024139149 | ||
| 003 | DE-627 | ||
| 005 | 20230307072723.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/rcr2.1016 |2 doi | |
| 035 | |a (DE-627)DOAJ024139149 | ||
| 035 | |a (DE-599)DOAJ87338fceae0a47a4b486ca9a00580c28 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC705-779 | |
| 100 | 0 | |a Dujrath Somboonviboon |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Sarcoidosis developing after COVID‐19: A case report |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract COVID‐19 has been implicated in the development of a range of autoimmune diseases and medical consequences. Sarcoidosis is an inflammatory disease with sustained granulomatous inflammation. The possible main pathogenesis of sarcoidosis is a dysregulation between immune response and certain environmental antigens. We present a case of sarcoidosis as an interesting sequela of COVID‐19. The patient was hospitalized due to SARS‐CoV‐2 without complication. Ten weeks after the illness, his chest computed tomography (CT) showed bilateral hilar, paratracheal and subcarinal lymph node enlargement. Endobronchial ultrasound with transbronchial needle aspiration (EBUS‐TBNA) was performed; pathologic findings were that of well‐formed non‐necrotizing granulomas. Complete eye examination reported panuveitis and papillitis in both eyes. On the basis of these findings, sarcoidosis was diagnosed. Therefore, sarcoidosis developing after COVID‐19 was suggested as a possible link between the viral infection and dysregulation of the inflammation process. However, further studies are needed to confirm this association. | ||
| 650 | 4 | |a COVID‐19 | |
| 650 | 4 | |a granulomatous | |
| 650 | 4 | |a sarcoidosis | |
| 650 | 4 | |a uveitis | |
| 653 | 0 | |a Diseases of the respiratory system | |
| 700 | 0 | |a Anan Wattanathum |e verfasserin |4 aut | |
| 700 | 0 | |a Narumon Keorochana |e verfasserin |4 aut | |
| 700 | 0 | |a Kittisak Wongchansom |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Respirology Case Reports |d Wiley, 2015 |g 10(2022), 9, Seite n/a-n/a |w (DE-627)DOAJ000057134 |x 20513380 |7 nnns |
| 773 | 1 | 8 | |g volume:10 |g year:2022 |g number:9 |g pages:n/a-n/a |
| 856 | 4 | 0 | |u https://doi.org/10.1002/rcr2.1016 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/87338fceae0a47a4b486ca9a00580c28 |z kostenfrei |
| 856 | 4 | 0 | |u https://doi.org/10.1002/rcr2.1016 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2051-3380 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 10 |j 2022 |e 9 |h n/a-n/a | ||